First Trust Advisors LP decreased its position in Landauer, Inc. (NYSE:LDR) by 26.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,919 shares of the scientific and technical instruments company’s stock after selling 2,850 shares during the period. First Trust Advisors LP owned 0.08% of Landauer worth $386,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in LDR. Guggenheim Capital LLC boosted its stake in shares of Landauer by 179.5% in the fourth quarter. Guggenheim Capital LLC now owns 23,654 shares of the scientific and technical instruments company’s stock worth $1,138,000 after buying an additional 15,192 shares during the period. State Street Corp boosted its stake in shares of Landauer by 5.7% in the fourth quarter. State Street Corp now owns 215,056 shares of the scientific and technical instruments company’s stock worth $10,343,000 after buying an additional 11,519 shares during the period. Metropolitan Life Insurance Co. NY boosted its stake in shares of Landauer by 0.5% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 7,270 shares of the scientific and technical instruments company’s stock worth $350,000 after buying an additional 36 shares during the period. Dimensional Fund Advisors LP raised its position in Landauer by 20.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 249,548 shares of the scientific and technical instruments company’s stock worth $12,003,000 after buying an additional 42,190 shares in the last quarter. Finally, Two Sigma Investments LP raised its position in Landauer by 6.0% in the fourth quarter. Two Sigma Investments LP now owns 33,635 shares of the scientific and technical instruments company’s stock worth $1,618,000 after buying an additional 1,910 shares in the last quarter. 82.16% of the stock is owned by institutional investors and hedge funds.
Landauer, Inc. (NYSE LDR) traded up 1.29% during trading on Friday, hitting $54.90. The stock had a trading volume of 31,198 shares. Landauer, Inc. has a 52-week low of $41.00 and a 52-week high of $55.95. The firm has a market cap of $529.18 million, a P/E ratio of 27.33 and a beta of 1.30. The company has a 50-day moving average of $53.81 and a 200 day moving average of $51.59.
Landauer (NYSE:LDR) last announced its quarterly earnings data on Tuesday, May 9th. The scientific and technical instruments company reported $0.54 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.04. Landauer had a net margin of 12.82% and a return on equity of 79.41%. The business had revenue of $39.12 million for the quarter. On average, equities research analysts predict that Landauer, Inc. will post $1.79 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Thursday, July 6th. Investors of record on Friday, June 16th were paid a dividend of $0.275 per share. The ex-dividend date of this dividend was Wednesday, June 14th. This represents a $1.10 annualized dividend and a yield of 2.00%. Landauer’s dividend payout ratio is currently 54.46%.
COPYRIGHT VIOLATION WARNING: This story was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.chaffeybreeze.com/2017/07/29/landauer-inc-ldr-position-decreased-by-first-trust-advisors-lp-updated-updated-updated.html.
Separately, Zacks Investment Research upgraded Landauer from a “sell” rating to a “hold” rating in a research note on Wednesday, July 12th.
Landauer Company Profile
Landauer, Inc is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products.
Receive News & Ratings for Landauer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.